Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions
The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases (LPD) in the Russian Federation in 2016- 2017. Materials and methods. Treating physicians in 75 regions of the Russian Federation were asked to fill the survey questionnaire containing 9 types of malign...
Saved in:
| Main Authors: | G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2019-01-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart rate variability in patients with lymphoproliferative diseases in remission
by: B. B. Samura
Published: (2018-08-01) -
Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin’s Lymphoma or Mantle-Cell Lymphoma
by: Brenda Cristie Edina, et al.
Published: (2022-07-01) -
Recent Progress of Exosomes in Hematological Malignancies: Pathogenesis, Diagnosis, and Therapeutic Strategies
by: Zhang H, et al.
Published: (2024-11-01) -
Knowledge-map and bibliometric analysis of scientific research on FDA-approved Chimeric Antigen Receptor T cell products (2015–2024)
by: Moutaz W. Sweileh
Published: (2025-08-01) -
Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress
by: Huageng Huang, et al.
Published: (2024-12-01)